March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
January 13, 2022
University of Cincinnati researchers have received a U.S. Department of Defense grant to further study how stress hormone receptors affect brain cell degeneration in Parkinson's disease.
January 20, 2022
University of Cincinnati researcher physicians are hosting the BEAT-MS trial which will study the effectiveness of stem cell transplant compared to the currently best available treatments for multiple sclerosis.
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.
November 19, 2021
University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.
October 11, 2021
The University of Cincinnati is opening a new clinical trial looking to see how the combination of immunotherapy and transplant can improve patient outcomes.
November 29, 2021
University of Cincinnati's Dr. Robert Van Haren recently published new research that shows lung cancer surgery outcomes between former and current smokers are similar enough that smoking should not be a barrier to offering surgery.
December 7, 2021
The University of Cincinnati's Dr. Vladimir Bogdanov has been awarded a Catalyst Research Award to further investigate if a drug he and his team developed is effective in treating pancreatic cancer.
January 4, 2022
The University of Cincinnati's Dr. Ishita Basu is researching how targeted electrical stimulation can be used as a treatment for mental health disorders.
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.